Skip to content
Clinical Trials – home
Fundacio Institut D'Investigacio Biomedica De Bellvitge IDIBELL
Sponsor

Fundacio Institut D'Investigacio Biomedica De Bellvitge IDIBELL

Spain Avinguda De La Gran Via De L'hospitalet 199, 08908 L'hospitalet De Llobregat, Spain

About the sponsor

Solid tumours are a major focus, including advanced solid tumours, germ cell tumours, metastatic uveal melanoma, and cutaneous squamous cell carcinoma. The portfolio also includes studies in tumour immune resistance and anti-PD-1 therapy.

  • Advanced solid tumours
  • Germ cell tumours
  • Metastatic uveal melanoma
  • Cutaneous squamous cell carcinoma

Research activity in this area includes cell-based immunotherapy, tumour response assessment, and the study of biomarkers linked to treatment resistance.

About Specializations

Fundacio Institut D'Investigacio Biomedica De Bellvitge IDIBELL runs clinical trials in conditions such as Renal transplant, Diabetes prophylaxis, Insomnia, Major depression, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

14 clinical trials

Insomnia+1

Recruiting
Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Daridorexant
  • Sponsor:Fundacio Institut D'Investigacio Biomedica De Bellvitge IDIBELL
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Ceftriaxone
  • Sponsor:Bellvitge University Hospital
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Cyclophosphamide
  • Sponsor:Fundacio Institut D'Investigacio Biomedica De Bellvitge IDIBELL
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Efgartigimod Alfa
  • Sponsor:Bellvitge University Hospital
Countries:SpainSpain
  • Participants:18–64 years
  • Substances:Human Papillomavirus Type 11 L1 Protein - Adsorbed - In The Form Of Virus-Like Particles Produced In Yeast Cells (Saccharomyces Cerevisiae Canade 3C-5 (Strain 1895)) By Rdna
  • Sponsor:Bellvitge University Hospital
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Cemiplimab
  • Sponsor:Fundacio Institut D'Investigacio Biomedica De Bellvitge IDIBELL

Uveal melanoma

Not recruiting
InvestigationalNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Allogenic Bone Marrow-Derived Mesenchymal Stem Cells Transduced With Icovir-5, Ex Vivo Expanded
  • Sponsor:Fundacio Institut D'Investigacio Biomedica De Bellvitge IDIBELL
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Loratadine
  • Sponsor:Fundacio Institut D'Investigacio Biomedica De Bellvitge IDIBELL

Adrenoleukodystrophy

Not recruiting
Registered drug
Countries:SpainSpain
  • Participants:18–64 years
  • Substances:Dimethyl Fumarate
  • Sponsor:Fundacio Institut D'Investigacio Biomedica De Bellvitge IDIBELL
Countries:SpainSpain
  • Participants:18–64 years
  • Substances:Aprepitant
  • Sponsor:Bellvitge University Hospital
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Aldesleukin
  • Sponsor:Fundacio Institut D'Investigacio Biomedica De Bellvitge IDIBELL
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Isoniazid
  • Sponsor:Bellvitge University Hospital

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.